Prothrombotic State in COVID-19: Myth or Reality?
作者信息
Bauer Philippe R
机构信息
Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, MN.
出版信息
Mayo Clin Proc. 2021 Jul;96(7):1694-1696. doi: 10.1016/j.mayocp.2021.05.015. Epub 2021 May 24.
Abstract
摘要
相似文献
1
Prothrombotic State in COVID-19: Myth or Reality?新冠病毒感染中的血栓前状态：虚构还是现实？
Mayo Clin Proc. 2021 Jul;96(7):1694-1696. doi: 10.1016/j.mayocp.2021.05.015. Epub 2021 May 24.
2
Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?羟氯喹降低风湿性疾病患者感染新冠病毒的风险：是误解还是事实？
Ann Rheum Dis. 2021 Jan;80(1):e6. doi: 10.1136/annrheumdis-2020-217556. Epub 2020 Apr 21.
3
Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie .对于抗疟药物在风湿性疾病患者的新型冠状病毒肺炎治疗中明确作用的界定仍为时过早。回应：谢的“羟氯喹降低风湿性疾病患者感染新型冠状病毒肺炎的风险：神话还是现实？”
Ann Rheum Dis. 2021 Jan;80(1):e7. doi: 10.1136/annrheumdis-2020-217633. Epub 2020 Jun 22.
4
Parasites Protect from Severe COVID-19. Myth or Reality?寄生虫可预防重症新冠？是谣言还是事实？
Int J Infect Dis. 2022 Jun;119:117-118. doi: 10.1016/j.ijid.2022.03.027. Epub 2022 Mar 22.
5
Response to Abdelrahman M et al commentary on "Parasites Protect from Severe COVID-19. Myth or Reality?".对阿卜杜勒拉赫曼等人关于“寄生虫预防重症新冠病毒病。神话还是现实？”评论的回应
Int J Infect Dis. 2022 Jul;120:46-47. doi: 10.1016/j.ijid.2022.04.012. Epub 2022 Apr 9.
6
The myth that Nigerians are immune to SARS-CoV-2 and that COVID-19 is a hoax are putting lives at risk.认为尼日利亚人对新冠病毒具有免疫力以及新冠疫情是骗局的谬论正将人们的生命置于危险之中。
J Glob Health. 2020 Dec;10(2):020375. doi: 10.7189/jogh.10.020375.
7
Sustained prothrombotic changes in convalescent patients with COVID-19.新冠康复患者持续存在的血栓前状态改变。
Lancet Haematol. 2021 Jul;8(7):e475. doi: 10.1016/S2352-3026(21)00146-0.
8
Against COVID-19: Inspired by Greek Myth.对抗新冠病毒：受希腊神话启发
Occup Med (Lond). 2020 Dec 12;70(8):612-613. doi: 10.1093/occmed/kqaa112.
9
Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons.儿童与成人 COVID-19 严重程度的年龄特异性差异：现实与原因。
Adv Exp Med Biol. 2021;1327:63-78. doi: 10.1007/978-3-030-71697-4_5.
10
SARS-CoV-2 seroprevalence in the Vatican City State.梵蒂冈城国的新冠病毒血清流行率。
Eur J Intern Med. 2021 Apr;86:98-99. doi: 10.1016/j.ejim.2021.01.029. Epub 2021 Feb 4.
引用本文的文献
1
Thrombosis Occurrence in COVID-19 Compared With Other Infectious Causes of ARDS: A Contemporary Cohort.COVID-19 与其他导致 ARDS 的感染性病因相比的血栓发生情况：一项当代队列研究。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231175656. doi: 10.1177/10760296231175656.
2
The GRACE risk score in patients with ST-segment elevation myocardial infarction and concomitant COVID-19.ST段抬高型心肌梗死合并新型冠状病毒肺炎患者的GRACE风险评分
Arch Med Sci Atheroscler Dis. 2022 Aug 10;7:e116-e123. doi: 10.5114/amsad/152107. eCollection 2022.
本文引用的文献
1
Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients. Mayo 诊所住院 COVID-19 阳性患者与 COVID-19 阴性患者的大血管血栓事件的全企业范围样本比较。
Mayo Clin Proc. 2021 Jul;96(7):1718-1726. doi: 10.1016/j.mayocp.2021.04.022. Epub 2021 May 4.
2
Pulmonary Embolism Does Not Have an Unusually High Incidence Among Hospitalized COVID19 Patients.住院 COVID19 患者中肺栓塞的发生率并不异常高。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029621996471. doi: 10.1177/1076029621996471.
3
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo 诊所治疗和研究模式下的 COVID-19 结果。
Mayo Clin Proc. 2021 Mar;96(3):601-618. doi: 10.1016/j.mayocp.2020.12.006. Epub 2020 Dec 26.
4
Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry.COVID-19 患者接受器官支持治疗的结果：国际病毒感染和呼吸道疾病通用研究登记处。
Crit Care Med. 2021 Mar 1;49(3):437-448. doi: 10.1097/CCM.0000000000004879.
5
A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019.一项关于 2019 年冠状病毒病住院患者静脉血栓栓塞症发生率、预后和实验室指标的系统评价和荟萃分析。
J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1099-1111.e6. doi: 10.1016/j.jvsv.2021.01.012. Epub 2021 Jan 30.
6
Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis.2019冠状病毒病的血栓栓塞风险很高，且与更高的死亡风险相关：一项系统评价和荟萃分析。
EClinicalMedicine. 2020 Dec;29:100639. doi: 10.1016/j.eclinm.2020.100639. Epub 2020 Nov 20.
7
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.COVID-19 住院患者静脉血栓栓塞症和出血的发生率：系统评价和荟萃分析。
Chest. 2021 Mar;159(3):1182-1196. doi: 10.1016/j.chest.2020.11.005. Epub 2020 Nov 17.
8
Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis.COVID-19 患者的静脉血栓栓塞症：系统评价和荟萃分析。
Thromb Res. 2020 Dec;196:67-74. doi: 10.1016/j.thromres.2020.08.020. Epub 2020 Aug 12.
9
Coagulopathy in COVID-19.新型冠状病毒疾病中的凝血功能障碍。
J Thromb Haemost. 2020 Sep;18(9):2103-2109. doi: 10.1111/jth.14975. Epub 2020 Jul 21.
Zotero 插件